Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
3.085
-0.055 (-1.75%)
Sep 11, 2026, 4:08 PM HKT
HKG:1066 Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HKG:1066 stock has a consensus rating of "Strong Buy" and an average price target of $5.38. The average 1-year stock price forecast is 74.39% higher than the current stock price, while the lowest is $3.87 (+25.45%) and the highest is $8.19 (+165.48%).
Price Target: $5.38 (+74.39%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:1066 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $4.15 | Buy | Maintains | $4.15 | +34.52% | Sep 6, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $5.10 | Buy | Maintains | $5.10 | +65.32% | Sep 1, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $6.00 → $4.80 | Buy | Maintains | $6.00 → $4.80 | +55.59% | Aug 27, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $4.80 | Buy | Maintains | $4.80 | +55.59% | Aug 27, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $3.86 | Hold | Maintains | $3.86 | +25.12% | Aug 26, 2026 |
Financial Forecast
Revenue This Year
13.81B
from 13.39B
Increased by 3.11%
Revenue Next Year
14.86B
from 13.81B
Increased by 7.64%
EPS This Year
0.33
from 0.36
Decreased by -7.64%
EPS Next Year
0.41
from 0.33
Increased by 25.54%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.